Diagnostic accuracy of serum insulin-like growth factor-binding protein 2 for ovarian cancer.

Pande Kadek Aditya PrayudiI Nyoman Gede BudianaPutu Doster MahayasaI Gede Ngurah Harry Wijaya SuryaAnak Agung Gede Putra WiradnyanaKetut Suwiyoga

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)

IGFBP2 is a novel and potentially promising biomarker for detecting ovarian cancer. Further studies are needed to confirm its diagnostic performance in premenopausal women and for detecting early stage ovarian cancer.

Keyphrases

early stage
binding protein
metabolic syndrome
adipose tissue
sentinel lymph node
insulin resistance